Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A phase II & open-labeled & multi-center & randomized controlled trial of Vinblastine +/- Bevacizumab for the treatment of chemotherapy-naive children with unresectable or progressive low grade glioma
Protocol ID
OZM-063 (LGG Avastin)
Disease (Sub Disease)
Brain and Spinal Tumours(Low Grade Gliomas)
Diagnosis Stage
New diagnosis
Relapse/ refractory
Location
NSW, QLD, VIC, WA, SA
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
The Hospital for Sick Children
Collaborators
Hoffmann-La Roche
Trial Status
Open
Sites
The Children's Hospital at Westmead
Perth Children's Hospital
Queensland Children's Hospital
Royal Children's Hospital
Women's & Children's Hospital
Study Type
Treatment
Phase
Phase 2
Age Eligibility
6 months to 18 years old
International registry ID's
NCT02840409
Back to Registry
Study Title A phase II & open-labeled & multi-center & randomized controlled trial of Vinblastine +/- Bevacizumab for the treatment of chemotherapy-naive children with unresectable or progressive low grade glioma
Protocol ID OZM-063 (LGG Avastin)
Disease (Sub Disease) Brain and Spinal Tumours(Low Grade Gliomas)
Diagnosis Stage New diagnosis
Relapse/ refractory
Location NSW / QLD / VIC / WA / SA
Sponsor Australian and New Zealand Children's Haematology Oncology Group/ The Hospital for Sick Children
Collaborators Hoffmann-La Roche
Links https://clinicaltrials.gov/ct2/show/NCT02840409
Trial Status Open
Trial Open Date 29/05/2018
Sites The Children's Hospital at Westmead / Perth Children's Hospital / Queensland Children's Hospital / Royal Children's Hospital / Women's & Children's Hospital /
Study Type Treatment
Phase Phase 2
Age Eligibility 6 months to 18 years old
International registry ID's NCT02840409